Literatur
- 1
Ferner R E.
The influence of big pharma.
BMJ.
2005;
330
855-856
- 2
Fontanarosa P B, Flanagin A, De Angelis C D.
Reporting conflicts of interest, financial aspects of research, and role of sponsors.
JAMA.
2005;
294
110-111
- 3
Mello M M, Clarridge B R, Studdert D M.
Academic medical centers’ standards for clinical-trial agreements with industry.
N Engl J Med.
2005;
352
2202-2210
- 4
Weatherall D.
Research conduct and the case of Nancy Olivieri.
Lancet.
2005;
366
445-446
- 5
Engelhardt K.
Der medizinisch-industrielle Komplex: Ethische Implikationen.
Dtsch Med Wochenschr.
2005;
130
1778-1780
Prof. Dr. med. Karlheinz Engelhardt
Jaegerallee 7
24159 Kiel
